Following this, we detected a tenfold increased expression of the alternative anti-apoptotic MCL1 in healthy CD34 + cells compared to lymphoma cell lines, protecting the progenitor cells from long-lasting abolishment of BCL2 by VEN. This evidence concerns the gene MCL1 and lymphoma.